| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate |
2002-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbc03c79d74250a6380f3846c15f3e15 |
| publicationDate |
2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003027854-A1 |
| titleOfInvention |
Methods for the treatment of itching comprising administering PGD2 receptor antagonists |
| abstract |
A PGD 2 receptor antagonist such as a compound of the formula (IA-a-5): n n n a pharmaceutical acceptable salt thereof or a hydrate thereof, has an efficacious activity for the prevention or treatment of itching and is useful as a medicament. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11333672-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11112403-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9797903-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11327071-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10408838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3382391-A1 |
| priorityDate |
1998-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |